Effects of acarbose on fecal nutrients, colonic pH, and short-chain fatty acids and rectal proliferative indices (Q71468483)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

title

Effects of acarbose on fecal nutrients, colonic pH, and short-chain fatty acids and rectal proliferative indices (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

author name string

E Atillasoy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

J Lindenbaum

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

S B Ho

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

J R Lupton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

D McMahon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

S F Moss

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

page(s)

1179-1187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

18 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Intestinal and metabolic responses to an alpha-glucosidase inhibitor in normal volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Nitrogen determination by a continuous digestion and analysis system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Digoxin-inactivating bacteria: identification in human gut flora

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

An approximate distribution of estimates of variance components.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Determinants and consequences of colonic luminal pH: implications for colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Dietary fat and fiber alter rat colonic mucosal lipid mediators and cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Effects of sodium sulfate on fecal pH and proliferation of colonic mucosa in patients at high risk for colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

The starved colon--diminished mucosal nutrition, diminished absorption, and colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Butyrate and phenylacetate as differentiating agents: practical problems and opportunities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Endogenous mutagens and the causes of aging and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Production and excretion of hydrogen gas in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Role of pH in production of hydrogen from carbohydrates by colonic bacterial flora. Studies in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Can diarrhea induced by lactulose be reduced by prolonged ingestion of lactulose?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Effect of long term lactulose ingestion on secondary bile salt metabolism in man: potential protective effect of lactulose in colonic carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Urinary excretion of reduced metabolites of digoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Unusually large digitalis requirements. A study of altered digoxin metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Fecal excretion, uptake and metabolism by colon mucosa of diacylglycerol in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

Gastrointestinal cancer: pathogenesis, risk factors and the development of intermediate biomarkers for chemoprevention studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Butyrate and colonic cytokinetics: differences between in vitro and in vivo studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990020-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0026-0495(96)90020-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8781308%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference